Stay updated on Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Sign up to get notified when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.

Latest updates to the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page
- Check2 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check9 days agoChange DetectedA notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record.SummaryDifference1%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check44 days agoChange DetectedAdds Revision: v3.7.0 and removes a large list of indexing terms related to conditions, pathogens, and study components from the record. The change affects metadata and search discoverability rather than the substantive study details.SummaryDifference18%

- Check65 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's metadata.SummaryDifference0.1%

Stay in the know with updates to Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.